Aminoalkylamides of Eremomycin Exhibit an Improved Antibacterial Activity

Area of Science:

• Microbiology
• Medicinal Chemistry
• Pharmacology

Background:

• Vancomycin remains crucial for Gram-positive bacterial infections, but resistance is a growing concern.
• Emerging resistance in *Staphylococcus aureus* and *Enterococcus* spp. necessitates novel therapeutic strategies.
• Understanding structure-activity relationships is key to developing effective glycopeptide antibiotics.

Purpose of the Study:

• To synthesize and evaluate novel eremomycin aminoalkylamides for antimicrobial activity.
• To investigate the structure-activity relationships of these new derivatives.
• To identify a lead compound for further preclinical development.

Main Methods:

• Synthesis of eremomycin conjugated with hydrophobic arylalkyl groups via alkylenediamine spacers.
• Antibacterial activity testing against vancomycin-sensitive and resistant Gram-positive bacterial strains.
• In vivo efficacy assessment using a *Staphylococcus* sepsis model and acute toxicity studies.

Main Results:

• Several novel eremomycin amide derivatives demonstrated significant antimicrobial potential.
• Structure-activity relationship analysis identified key features for enhanced antibacterial activity.
• A lead compound exhibited favorable efficacy in an in vivo sepsis model with a good therapeutic index.

Conclusions:

• The developed eremomycin aminoalkylamides represent a promising class of novel antibiotics.
• The study highlights the potential of modifying eremomycin to overcome existing resistance mechanisms.
• The selected lead compound warrants further investigation for clinical application against resistant Gram-positive infections.